# Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)

> **NCT03986138** · PHASE3 · COMPLETED · sponsor: **Guerbet** · enrollment: 324 (actual)

## Conditions studied

- Lesion in Body Region

## Interventions

- **DRUG:** gadopiclenol
- **DRUG:** Gadobutrol 1 MMOLE/ML Intravenous Solution

## Key facts

- **NCT ID:** NCT03986138
- **Lead sponsor:** Guerbet
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-27
- **Primary completion:** 2020-12-09
- **Final completion:** 2020-12-09
- **Target enrollment:** 324 (ACTUAL)
- **Last updated:** 2025-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03986138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03986138, "Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03986138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*